Category: Latest Research
-
TGen-led study suggest a drug combination that might prove effective for 1 in 3 glioblastoma patients
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first new drug treatment in more than a decade for glioblastoma, the most common and aggressive type of brain cancer.…
-
7th Annual ABRC-Flinn Research Conference highlights wide range of translational research
Translational research in pancreatic and chronic lung diseases, opioid receptors, West Nile Virus, Rocky Mountain Spotted Fever transmission, autism in older adults and insulin-dependent diabetes were among the topics discussed at the 7th ABRC-Flinn Research Conference.
-
TGen, HonorHealth and Irish biomedical team initiate promising ‘Nieto’ clinical trial against pancreatic cancer
association with HonorHealth Research and Innovation Institute and Systems Biology Ireland (SBI), have begun a clinical trial, testing the combination of two drugs against advanced pancreatic cancer, one of the most deadly and difficult-to-treat malignancies.
